These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Fluoxetine in the treatment of obsessive compulsive disorder. Fontaine R; Chouinard G Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):605-8. PubMed ID: 3878975 [TBL] [Abstract][Full Text] [Related]
7. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. Simeon JG; Thatte S; Wiggins D Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627 [TBL] [Abstract][Full Text] [Related]
8. Three cases of pharmacotherapy of obsessive-compulsive disorder in the elderly. Austin LS; Zealberg JJ; Lydiard RB J Nerv Ment Dis; 1991 Oct; 179(10):634-5. PubMed ID: 1919549 [No Abstract] [Full Text] [Related]
9. Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy. Jenike MA; Baer L; Greist JH J Clin Psychopharmacol; 1990 Apr; 10(2):122-4. PubMed ID: 2140372 [TBL] [Abstract][Full Text] [Related]
10. Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine. Mattes JA Am J Psychiatry; 1994 Oct; 151(10):1524. PubMed ID: 8092352 [No Abstract] [Full Text] [Related]
11. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine]. Volk S Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392 [No Abstract] [Full Text] [Related]
12. Pharmacotherapy of obsessive-compulsive disorder. Klein DF Encephale; 1990; 16 Spec No():331-4. PubMed ID: 2209491 [TBL] [Abstract][Full Text] [Related]
13. Fluoxetine treatment of obsessive-compulsive disorder. Solyom L; Solyom C; Ledwidge B Can J Psychiatry; 1991 Dec; 36(10):723-7. PubMed ID: 1790516 [TBL] [Abstract][Full Text] [Related]
14. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder. Fontaine R; Chouinard G J Clin Psychopharmacol; 1986 Apr; 6(2):98-101. PubMed ID: 3517083 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of obsessive-compulsive disorder. Jermain DM; Crismon ML Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535 [TBL] [Abstract][Full Text] [Related]
17. The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. Diniz JB; Costa DL; Cassab RC; Pereira CA; Miguel EC; Shavitt RG J Psychopharmacol; 2014 Jun; 28(6):603-11. PubMed ID: 24288238 [TBL] [Abstract][Full Text] [Related]
18. The pharmacotherapy of moral or religious scrupulosity. Fallon BA; Liebowitz MR; Hollander E; Schneier FR; Campeas RB; Fairbanks J; Papp LA; Hatterer JA; Sandberg D J Clin Psychiatry; 1990 Dec; 51(12):517-21. PubMed ID: 2258366 [TBL] [Abstract][Full Text] [Related]